Hydreight Technologies Inc.NURS.VReports Mon, Aug 31 · Q2 2026

Health Care · Health Care Equipment & Services · TSX-V · Canada · hydreight.com

Hydreight Technologies Inc. is a Canadian telehealth platform and mobile clinic network enabling licensed healthcare professionals — including nurses and medical practitioners — to deliver mobile health services directly to patients across 50 U.S. states. The company's integrated platform supports over 2,500 nurses and 100 doctors with tools for booking, HIPAA-compliant documentation, pharmaceutical access, and compliance, offering services including IV therapy, GLP-1 weight loss treatments, NAD+, and other wellness therapies. Hydreight also trades on the OTC Markets under the symbol HYDTF.

Key ratios

Operating cash flow growth

93.6%TTM

FCF / Sales

-12.7%TTM

2025 -5.3%2024 5.3%2023 -3.5%

Net margin

7.6%TTM

2025 4.8%2024 -2.5%2023 -16.8%

ROA

9.0%TTM

2025 4.7%2024 -9.7%2023 -44.0%

ROE

21.5%TTM

2025 18.9%

Revenue growth

120.5%2025

2024 39.4%2023 169.6%

Recent news

Hydreight Reports Record Q2 2026 Revenue of $28.0 Million, Net Income of $2.5 Million and Adjusted EBITDA of $3.2 Million 2026-09-01 · CNW Hydreight Technologies Announces Timing of Q2 2026 Financial Results and Investor Webcast Featuring Live Analyst Q&A 2026-08-27 · CNW Hydreight to Participate in Canaccord Genuity's 46th Annual Growth Conference in Boston 2026-08-06 · CNW Hydreight Provides Business Update on its Peptide Healthcare Platform Following FDA Advisory Committee Recommendations 2026-07-29 · CNW Hydreight Delivers Record First Quarter 2026 Revenue of $24.9 Million with 449% Revenue Growth, $3.3 Million in Adjusted EBITDA and $32.0 Million in Working Capital 2026-06-01 · Newswire Canada Hydreight Technologies Closes Strategic Investment in Insu Therapeutics 2026-03-13 · Newswire Canada Hydreight Technologies Issues Fiscal 2026 Revenue Guidance of ≈ $150 Million and Provides Q1 2026 Outlook 2026-02-02 · Barchart

Track NURS.V in your journal

Save it to a watchlist, run a reverse DCF, and keep your notes on the company in one place. Free to start.

Create a free account

Figures are sourced from third parties and shown for research only. They may be delayed or incomplete, and nothing on this page is investment advice or a recommendation to buy or sell. Read the full disclaimer